Current Clinical Practice: Management of the Chronic Leukemias: Special Considerations in the Elderly Patient. Part III. Rarer Chronic Myeloid Leukemias

References

• Fialkow, P.J., Jacobson, R.J., Singer, J.W., et al. (1980) “Philadelphia chromosome (Ph1)-negative chronic myelogenous leukemia (CML): a clonal disease with origin in a multipotent stem cell”, Blood 56, 70–73.
   PubMed Web of Science ®Google Scholar
• Krauss, S., Sokal, J.E. and Sandberg, A. A. (1964) “Comparison of Philadelphia chromosome-positive and -negative patients with chronic myelocytic leukemia”, Ann. Intern. Med. 61, 625–635.
   PubMed Web of Science ®Google Scholar
• Ezdinli, E.Z., Sokal, J.E., Crosswhite, L., et al., (1970) “Philadelphia-chromosome-positive and -negative chronic myelocytic leukemia”, Ann. Intern. Med. 72, 175–182.
   PubMedGoogle Scholar
• Hays, T., Morse, H., Peakman, D., et al., (1979) “Cytogenetic studies of chronic myelocytic leukaemia in children and adolescents”. Cancer 44, 210–214.
   PubMed Web of Science ®Google Scholar
• Mintz, U., Vardiman, J., Golomb, H.M., et al., (1979) “Evolution of karyotypes in Philadelphia (Ph1) chromosome-negative chronic myelogenous leukaemia”, Cancer 43, 411–416.
   PubMed Web of Science ®Google Scholar
• Gunz, F. and Baikie, A.G. (1974) “The pathology and pathophysiology of the leukemia cell”, In: Leukemia, 3rd ed. (Grune & Stratton, New York), pp 133–174.
   Google Scholar
• Gralnick, H.R., Galton, D.A.G., Catovsky, D., et al., (1977) “Classification of acute leukemia”, Ann. Intern. Med. 87, 740–753.
   PubMed Web of Science ®Google Scholar
• Sultan, C., Pierre, R.V., Hast, R., et al., (1980) “Refractory anemias and dysmyelopoietic syndromes (DMPS)”, Educ. Prog. Am. Soc. Hematol Montreal, 22–26.
   Google Scholar
• Storniolo, A.M., Moloney, W.C., Rosenthal, D.S., et al., (1986) “Myelodysplasia with monocytosis: the chronic myelodys-plastic syndromes”, Blood 68 (206a), 701.
   Google Scholar
• Mufti, G.J., Stevens, J.R., Oscier, D.G., et al., (1985) “Myelodysplastic syndromes: a scoring system with prognostic significance”, Br. J. Haematol. 59, 425–433.
   PubMed Web of Science ®Google Scholar
• Beran, M. and Kantarjian, H. (1998) “Topotecan in the treatment of hematologic malignancies”, Semin. Hematoi. 35, 26–31.
   PubMed Web of Science ®Google Scholar
• You, W. and Weisbrot, I.M. (1979) “Chronic neutrophilic leukemia. Report of two cases and review of the literature”, Am. J. Clin. Pathol. 72, 233–242.
   PubMed Web of Science ®Google Scholar
• Pane, F., Frigeri, F., Sindona, M., et al., (1996) “Neutrophilic—chronic myeloid leukemia: a distinct disease with a specific molecular marker 9BCR/ABL with C3/A2 junction”, Blood 88, 2410–2414.
   PubMed Web of Science ®Google Scholar
• Terre, C., Garcia, I., Bastie, J.N., et al., (1999) “A case of chronic neutrophilic leukemia with deletion (11) (q23)”, Cancer Genet. Cytogenet. 110, 70–71.
   PubMedGoogle Scholar
• Chusid, M.J., Dale, D.C., West, B.C., et al., (1975) “The hypereosinophilic syndrome”, Medicine 54, 1–27.
   PubMed Web of Science ®Google Scholar
• Parrillo, J.E., Fauci, A.S. and Wolff, S.M. (1978) “Therapy of the hypereosinophilic syndrome”, Ann. Intern. Med. 89, 167–172.
   PubMed Web of Science ®Google Scholar
• Spitzer, G. and Garson, O.M. (1973) “Lymphoblastic leukemia with marked eosinophils: a report of two cases”, Blood 43, 377–384.
   Google Scholar
• Catovsky, D., Bernasconi, C., Verdonck, P.J., et al., (1980) “The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patients”, Br. J. Haematol. 45, 523–534.
   PubMed Web of Science ®Google Scholar
• Bass, D.A. (1979) “The functions of eosinophils”, Ann. Intern. Med. 91, 120–121.
   PubMed Web of Science ®Google Scholar
• Tantravahi, R., Schwerin, M., Henkle, C., et al., (1984) “A pericentric inversion of chromosome 16 is associated with dysplastic marrow eosinophils in acute myelomonocytic leukemia”, Blood 63, 800–802.
   PubMed Web of Science ®Google Scholar
• Kauer, G.L. and Engle, R.L. (1964) “Eosinophilic leukaemia with Ph1-positive cells”, Lancet (2), 1340.
   Google Scholar
• Gruenwalk, H., Kiossoglou, K.A., Mitus, W.J., et al., (1965) “Philadelphia chromosome in eosinophilic leukemia”. Am. J. Med. 39, 1003–1010.
   PubMed Web of Science ®Google Scholar
• Gershwin, M.E., Fajardo, L.P., Gurwith, M., et al., (1972) “Eosinophilia terminating in myeloblastoma”, Am. J. Med. 53, 348–353.
   PubMed Web of Science ®Google Scholar
• Huang, C.S., Gomez, G.A., Kohno, S., et al., (1979) “Chromosomes and causation of human cancer and leukemia. XXXIV. A case of ‘hypereosinophilic syndrome’ with unusual cytogenetic findings in a chloroma, terminating in blastic transformation and CNS leukemia”, Cancer 44, 1284–1289.
   PubMed Web of Science ®Google Scholar
• Hardy, W.R. and Anderson, R.E. (1968) “The hypereosinophilic syndromes”, Ann. Intern. Med. 68, 1220–1229.
   PubMed Web of Science ®Google Scholar
• Yam, L.T., Li, C.Y., Necheles, T.F., et al., (1972) “Pseudoeosinophilia, eosinophilic endocarditis and eosinophilic leukemia”, Am. J. Med. 53, 193–202.
   PubMed Web of Science ®Google Scholar
• Benvenisti, D.S. and Ultmann, J.E. (1969) “Eosinophilic leukemia”, Ann. Intern. Med. 71, 731–745.
   PubMed Web of Science ®Google Scholar
• Parrillo, J.E. (1990) “Heart disease and the eosinophil”, N. Engl. J. Med. 323, 1560–1561.
   PubMed Web of Science ®Google Scholar
• Flannery, E.P., Freeman, M.V.R., D'Ambrosio, U., et al, (1972) “Eosinophilic leukemia with fibrosing endocarditis and short Y chromosome”, Ann. Intern. Med. 77, 223–228.
   PubMed Web of Science ®Google Scholar
• Resnick, M. and Myrrson, R.M. (1971) “Hypereosinophilic syndrome”, Am. J. Med. 51, 560–564.
   PubMed Web of Science ®Google Scholar
• Weinger, R.S., Andre-Schwartz, J., Desforges, J.F., et al, (1975) “Acute leukaemia with eosinophilia or eosinophilic leukaemia: a dilemma”, Br. J. Haematol. 30, 65–70.
   PubMed Web of Science ®Google Scholar
• Hamilton, P.J. and Dawson, A.A. (1977) “Successful treatment of apparent eosinophilic leukaemia”, Br. Med. J. (1), 1195.
   Google Scholar
• Youman, J.D., Taddeini, L. and Cooper, T. (1973) “Histamine excess symptoms in basophilic chronic granulocytic leukemia”, Arch. Intern. Med. 131, 560–562.
   PubMed Web of Science ®Google Scholar
• Cuneo, A., Kerim, S., Vandenberghe, E., et al, (1989) “Translocation t(6;9) occurring in acute myelofibrosis, myelodysplastic syndrome, and acute nonlymphocytic leukemia suggests multipotent stem cell involvement”, Cancer Genet. Cytogenet. 42, 209–219.
   PubMedGoogle Scholar
• Sagher, F. and Even-Paz, Z. (1967) Mastocytosis and the Mast Cell (Karger, Basel).
   Google Scholar
• Coser, P., Quaglino, D., De Pasquale, A., et al, (1980) “Cytobiological and clinical aspects of tissue mast cell leukaemia”, Br. J. Haematol. 45, 5–12.
   PubMed Web of Science ®Google Scholar
• Sater, N.A., Austen, K.F. and Wasserman, S.I. (1979) “Oral disodium cromoglycate in the treatment of systemic mastocytosis”, N. Engl. J. Med. 301, 465–469.
   PubMed Web of Science ®Google Scholar
• Mutter, R.D., Tannenbaum, M. and Ultmann, J.E. (1963) “Systemic mast cell disease”, Ann. Intern. Med. 59, 887–906.
   PubMed Web of Science ®Google Scholar
• Daniel, M.T., Flandrin, G. and Bernard, J. (1975) “Leucemie aigue a mastocytes”, Nouv Rev Franc d'Hematologie 15, 319–332.
   PubMedGoogle Scholar
• Foley, H.T., Bennett, J.M. and Carbone, P.P. (1969) “Combination chemotherapy in accelerated phase of chronic granulocytic leukemia”, Arch. Intern. Med. 123, 166–170.
   PubMed Web of Science ®Google Scholar
• Spiers, A.S.D., Bain, B.J. and Turner, J.E. (1977) “The Peripheral blood in chronic granulocytic leukaemia. Study of 50 untreated Philadelphia-positive cases”, Br. J. Haematoli. (18), 25–38.
   Google Scholar